Concepedia

Shaojian An

SA

Statistics

Publications

3

Citations

83

H-Index

3

Active since

2021

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Shaojian An is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and targeted protein degradation.

ORCID

Publications per year

2021–2024

3

Publications

3

Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons

C García Sánchez, Christopher M. Acker, Audrey Gray et al. · Communications Biology · 2021 · 30 citations · Full text

, , +17

Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase

Klemens Hoegenauer, Shaojian An, Jake Axford et al. · ACS Medicinal Chemistry Letters · 2023 · 29 citations · Full text

, , +12

Small molecule induced STING degradation facilitated by the HECT ligase HERC4

Merve Mutlu, Isabel Schmidt, Andrew I. Morrison et al. · Nature Communications · 2024 · 24 citations · Full text

, , +14

1–3 of 3